Comments on ‘Skin transplantation to monitor clinical donor‐related tolerance in mixed hematopoietic chimerism’ by Mache et al. (Pediatr Transplant 2006;10:128–131)
2006; Wiley; Volume: 10; Issue: 6 Linguagem: Inglês
10.1111/j.1399-3046.2006.00548.x
ISSN1399-3046
AutoresChristian Urban, Herwig Lackner, Martin Benesch, Petra Sovinz, Hans Jürgen Dornbusch, Andrea Moser, Wolfgang Schwinger,
Tópico(s)Polyomavirus and related diseases
ResumoPediatric TransplantationVolume 10, Issue 6 p. 749-750 Comments on ‘Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism’ by Mache et al. (Pediatr Transplant 2006;10:128–131) Christian Urban, Christian Urban Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorHerwig Lackner, Herwig Lackner Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorMartin Benesch, Martin Benesch Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorPetra Sovinz, Petra Sovinz Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorHans Jürgen Dornbusch, Hans Jürgen Dornbusch Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorAndrea Moser, Andrea Moser Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorWolfgang Schwinger, Wolfgang Schwinger Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this author Christian Urban, Christian Urban Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorHerwig Lackner, Herwig Lackner Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorMartin Benesch, Martin Benesch Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorPetra Sovinz, Petra Sovinz Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorHans Jürgen Dornbusch, Hans Jürgen Dornbusch Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorAndrea Moser, Andrea Moser Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this authorWolfgang Schwinger, Wolfgang Schwinger Department of Pediatrics and Adolescent Medicine Division of Pediatric Hematology/Oncology Medical University of Graz, Graz, Austria Tel.: 0043 316 385 3485 Fax: 0043 316 385 3450 E-mail: [email protected]Search for more papers by this author First published: 26 May 2006 https://doi.org/10.1111/j.1399-3046.2006.00548.xCitations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Mache CJ, Schwinger W, Spendel S, Zach O, Regauer S, Ring E. Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism. Pediatr Transplant 2006: 10: 128– 131. 2 Iacomini J. Monitoring tolerance induction. Pediatr Transplant 2006: 10: 5– 6. 3 Benesch M, Urban C, Sykora KW, et al. Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anemia. Br J Hematol 2004: 125: 58– 63. 4 Urban C, Benesch M, Sykora KW, Schwinger W, Lackner H. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia. Bone Marrow Transplant 2005: 35: 591– 594. 5 Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2001: 7: 473– 485. 6 Helg C, Chapuis B, Bolle JF, et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 1994: 58: 1420– 1422. 7 Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM, Cohen EP. Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transplant 1999: 13: 330– 335. 8 Hamawi K, De Magalhaes-Silverman M, Bertolatus JA. Outcomes of renal transplantation following bone marrow transplantation. Am J Transplant 2003: 3: 301– 305. 9 Storb R, Thomas ED, Buckner CD, et al. Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long term survivors. Blood 1976: 48: 485– 490. 10 Knobler HY, Sagher U, Peled IJ, et al. Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor. Transplantation 1985: 40: 223– 225. 11 Russell PS, Chase CM, Sykes M, Ito H, Shaer J, Colvin RB. Tolerance, mixed chimerism and chronic transplant arteriopathy. J Immunol 2001: 167: 5731– 5740. 12 Steinmüller D. Skin allograft rejection by stable hematopoietic chimeras that accept organ allografts still is an enigma. Transplantation 2001: 72: 8– 9. 13 Fuchimoto Y, Gleit ZL, Huang CA, et al. Skin-specific alloantigens in miniature swine. Transplantation 2001: 72: 122– 126. 14 Mathes DW, Randolph MA, Solari MG, et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 2003: 75: 25– 31. Citing Literature Volume10, Issue6September 2006Pages 749-750 ReferencesRelatedInformation
Referência(s)